Global Prostate Cancer Market Forecast to 2022 with Heat Map and Analysis

Prostate Cancer - Heat Map and Analysis report provides heat map framework for Prostate Cancer, designed to provide an easily digestible summary of these clinical characteristics, provides detailed readouts of all late-stage clinical trial results for products.

Prostate Cancer - Heat Map and Analysis report provides a detailed analysis of the clinical benchmarks set by the current market landscape Prostate Cancer and the anticipated changes to these benchmarks, and to the treatment algorithm, as a result of the late-stage pipeline. This tabular heat map framework, designed to provide an easily digestible summary of these clinical characteristics, provides detailed information on all late-stage clinical trial results for products in the PC market and late-stage pipeline. These are split along therapy lines, and are therefore reflective of the treatment algorithm.

Complete report on Prostate Cancer - Heat Map and Analysis Spread across 21 pages is available at

The PC market consists of therapies for both hormone-sensitive and castration-resistant forms of the disease. The options available for the two forms are notably different, with hormonal therapies used in the hormone-sensitive stage and chemotherapy or targeted therapies used in the castration-resistant stage. Castration-resistant PC relates to both symptomatic and asymptomatic forms of the disease that no longer respond to hormonal therapy.

Major Points Covered in Table of Contents
• Changes to Hormone-Sensitive Localized Disease, 2016-2022
• Changes to Hormone-Sensitive Metastatic Prostate Cancer, 2016-2022
• Changes to Metastatic Castration-Resistant Prostate Cancer, 2016-2022

Purchase a Copy of Report at:

•What are the clinical characteristics of currently approved therapies for PC, in terms of specific safety and efficacy parameters?
•What are the key unmet needs in this indication, and which clinical safety and efficacy parameters are most closely linked to them?
•Which novel classes of therapy are expected to emerge in the treatment of PC?
•Which targets do these therapies act upon?
•Which sub-types of patients could potentially benefit from these new products?

Complete report is Available at:

Reasons to buy
Understand the current clinical landscape by considering the treatment options available for each patient segment. Visually compare the currently approved treatments available at each line of therapy, based on the most important efficacy and safety parameters tested in clinical trials. Assess the current late-stage pipeline, in terms of the likely positioning of each product and the implications for the clinical landscape at each line of therapy.
Understand the relative strengths and weaknesses of the studies used to gather these data. Build up a nuanced understanding of the clinical benchmarks set by these products, and considers how the current late-stage pipeline will affect these benchmarks. Assess your own pipeline programs in light of these benchmarks in order to optimally position them and maximize uptake by clinicians.

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact Info:
Name: Ritesh Tiwari
Email: Send Email
Organization: ReportsandReports
Phone: + 1 888 391 5441

Release ID: 161698